Tursiella Melissa L, Bowman Emily R, Wanzeck Keith C, Throm Robert E, Liao Jason, Zhu Junjia, Sample Clare E
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, and the Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America.
Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
PLoS Pathog. 2014 Oct 2;10(10):e1004415. doi: 10.1371/journal.ppat.1004415. eCollection 2014 Oct.
Latent infection by Epstein-Barr virus (EBV) is highly associated with the endemic form of Burkitt lymphoma (eBL), which typically limits expression of EBV proteins to EBNA-1 (Latency I). Interestingly, a subset of eBLs maintain a variant program of EBV latency - Wp-restricted latency (Wp-R) - that includes expression of the EBNA-3 proteins (3A, 3B and 3C), in addition to EBNA-1. In xenograft assays, Wp-R BL cell lines were notably more tumorigenic than their counterparts that maintain Latency I, suggesting that the additional latency-associated proteins expressed in Wp-R influence cell proliferation and/or survival. Here, we evaluated the contribution of EBNA-3A. Consistent with the enhanced tumorigenic potential of Wp-R BLs, knockdown of EBNA-3A expression resulted in abrupt cell-cycle arrest in G0/G1 that was concomitant with conversion of retinoblastoma protein (Rb) to its hypophosphorylated state, followed by a loss of Rb protein. Comparable results were seen in EBV-immortalized B lymphoblastoid cell lines (LCLs), consistent with the previous observation that EBNA-3A is essential for sustained growth of these cells. In agreement with the known ability of EBNA-3A and EBNA-3C to cooperatively repress p14(ARF) and p16(INK4a) expression, knockdown of EBNA-3A in LCLs resulted in rapid elevation of p14(ARF) and p16I(NK4a). By contrast, p16(INK4a) was not detectably expressed in Wp-R BL and the low-level expression of p14(ARF) was unchanged by EBNA-3A knockdown. Amongst other G1/S regulatory proteins, only p21(WAF1/CIP1), a potent inducer of G1 arrest, was upregulated following knockdown of EBNA-3A in Wp-R BL Sal cells and LCLs, coincident with hypophosphorylation and destabilization of Rb and growth arrest. Furthermore, knockdown of p21(WAF1/CIP1) expression in Wp-R BL correlated with an increase in cellular proliferation. This novel function of EBNA-3A is distinct from the functions previously described that are shared with EBNA-3C, and likely contributes to the proliferation of Wp-R BL cells and LCLs.
爱泼斯坦-巴尔病毒(EBV)的潜伏感染与地方性伯基特淋巴瘤(eBL)密切相关,后者通常将EBV蛋白的表达限制为EBNA-1(潜伏I型)。有趣的是,一部分eBL维持着EBV潜伏的一种变体程序——Wp限制潜伏(Wp-R),除了EBNA-1外,还包括EBNA-3蛋白(3A、3B和3C)的表达。在异种移植试验中,Wp-R BL细胞系的致瘤性明显高于维持潜伏I型的细胞系,这表明Wp-R中表达的额外潜伏相关蛋白影响细胞增殖和/或存活。在此,我们评估了EBNA-3A的作用。与Wp-R BL增强的致瘤潜力一致,敲低EBNA-3A的表达导致细胞在G0/G1期突然停滞,同时视网膜母细胞瘤蛋白(Rb)转化为低磷酸化状态,随后Rb蛋白丢失。在EBV永生化的B淋巴母细胞系(LCLs)中也观察到了类似结果,这与之前观察到的EBNA-3A对这些细胞的持续生长至关重要的结果一致。与EBNA-3A和EBNA-3C协同抑制p14(ARF)和p16(INK4a)表达的已知能力一致,在LCLs中敲低EBNA-3A导致p14(ARF)和p16I(NK4a)迅速升高。相比之下,p16(INK4a)在Wp-R BL中未检测到表达,并且EBNA-3A敲低后p14(ARF)的低水平表达没有变化。在其他G1/S调节蛋白中,只有p21(WAF1/CIP1),一种有效的G1期停滞诱导剂,在Wp-R BL Sal细胞和LCLs中敲低EBNA-3A后上调,与Rb的低磷酸化和不稳定以及生长停滞同时发生。此外,在Wp-R BL中敲低p21(WAF1/CIP1)的表达与细胞增殖增加相关。EBNA-3A的这种新功能不同于先前描述的与EBNA-3C共有的功能,并且可能有助于Wp-R BL细胞和LCLs的增殖。